JP2017520619A - セリチニブ製剤 - Google Patents

セリチニブ製剤 Download PDF

Info

Publication number
JP2017520619A
JP2017520619A JP2017514990A JP2017514990A JP2017520619A JP 2017520619 A JP2017520619 A JP 2017520619A JP 2017514990 A JP2017514990 A JP 2017514990A JP 2017514990 A JP2017514990 A JP 2017514990A JP 2017520619 A JP2017520619 A JP 2017520619A
Authority
JP
Japan
Prior art keywords
ceritinib
tablet
weight percent
pharmaceutical composition
binder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017514990A
Other languages
English (en)
Other versions
JP2017520619A5 (ja
JP6679578B2 (ja
Inventor
ブリューレス,セバスチャン
エンスリン,シモン
Original Assignee
ノバルティス アーゲー
ノバルティス アーゲー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US201462004359P priority Critical
Priority to US62/004,359 priority
Application filed by ノバルティス アーゲー, ノバルティス アーゲー filed Critical ノバルティス アーゲー
Priority to PCT/IB2015/053966 priority patent/WO2015181739A1/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53298568&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2017520619(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of JP2017520619A publication Critical patent/JP2017520619A/ja
Publication of JP2017520619A5 publication Critical patent/JP2017520619A5/ja
Application granted granted Critical
Publication of JP6679578B2 publication Critical patent/JP6679578B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links